Parkmead Group PLC
F:LYK1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Parkmead Group PLC
F:LYK1
|
UK |
|
A
|
Anheuser-Busch Inbev SA
DUS:1NBA
|
BE |
|
A
|
Autodesk Inc
DUS:AUD
|
US |
|
SPAR Group Ltd
OTC:SGPPY
|
ZA |
|
Stride Inc
NYSE:LRN
|
US |
|
O
|
Organizacion Soriana SAB de CV
SWB:OSOB
|
MX |
|
Tesmec SpA
MIL:TES
|
IT |
|
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
|
IL |
|
O
|
Orient Overseas (International) Ltd
XBER:ORI1
|
HK |
|
M
|
Marriott International Inc
XMUN:MAQ
|
US |
|
Mitsui O.S.K. Lines Ltd
F:MIL
|
JP |
|
Cullinan Oncology Inc
NASDAQ:CGEM
|
US |
Wall St Price Targets
LYK1 Price Targets Summary
Parkmead Group PLC
According to Wall Street analysts, the average 1-year price target for
LYK1 is 0.48 EUR with a low forecast of 0.47 EUR and a high forecast of 0.49 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LYK1's stock price target?
Price Target
0.48
EUR
According to Wall Street analysts, the average 1-year price target for
LYK1 is 0.48 EUR with a low forecast of 0.47 EUR and a high forecast of 0.49 EUR.
What is the Gross Profit forecast for Parkmead Group PLC?
Projected CAGR
143%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 1 year is 143%.
What is the Pre-Tax Income forecast for Parkmead Group PLC?
Projected CAGR
-13%
The compound annual growth rate for Pre-Tax Income over the next 1 year is -13%.